Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313321 · ClinicalTrials.gov registry record
Survival of the Insignia Stem in Total Hip Arthroplasty
A clinical trial of Primary Total Hip Arthroplasty, sponsored by University of Utah.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05313321 is a study of Primary Total Hip Arthroplasty that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05313321, a study of Primary Total Hip Arthroplasty, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines \<2mm.
Conditions Studied
Interventions
- DEVICE Primary total hip arthroplasty receiving the Insignia Stem
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2028-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05313321
The ClinicalTrials.gov registry entry for NCT05313321 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Total Hip Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Primary total hip arthroplasty receiving the Insignia Stem is the first listed.
NCT05313321 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05313321 about?
NCT05313321 is a clinical study titled "Survival of the Insignia Stem in Total Hip Arthroplasty". The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing...
What is the current status of trial NCT05313321?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2022-03-17. Estimated completion is 2028-03.
What conditions does trial NCT05313321 study?
This clinical trial studies the following conditions: Primary Total Hip Arthroplasty.
What interventions are being tested in trial NCT05313321?
The interventions under investigation include: Primary total hip arthroplasty receiving the Insignia Stem (DEVICE).
Who is sponsoring clinical trial NCT05313321?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05313321 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Total Hip Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.